Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Presidential Symposium 3 – Discussion session II: Sars-CoV-2 and cancer

Q&A and live discussion

Date

20 Sep 2021

Session

Presidential Symposium 3 – Discussion session II: Sars-CoV-2 and cancer

Topics

COVID-19 and Cancer

Tumour Site

Presenters

Marie von Lilienfeld-Toal

Authors

E. Romano1, S.T.C. Shepherd2, S. Oosting3, M. von Lilienfeld-Toal4

Author affiliations

  • 1 Medical Oncology Department, Institut Curie, 75005 - Paris/FR
  • 2 Medical Oncology Department, The Royal Marsden Hospital - Chelsea, SW3 6JJ - London/GB
  • 3 Medical Oncology Department, UMCG - University Medical Center Groningen, 9700 RB - Groningen/NL
  • 4 Universitätsklinikum Jena, 07743 - Jena/DE

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.